Emerging Therapies for HER2-Positive Metastatic Breast Cancer
EP. 1: Perioperative Treatment of Early Stage HER2+ Breast Cancer
December 24th 2019
EP. 2: Treatment for High- and Low-Risk HER2+ Breast Cancer
December 24th 2019
EP. 3: Treatments for Relapsed/Refractory HER2+ Breast Cancer
December 24th 2019
EP. 4: Unmet Needs in Relapsed/Refractory HER2+ Breast Cancer
December 24th 2019
EP. 5: Trastuzumab Deruxtecan for the Treatment of HER2+ Breast Cancer
December 24th 2019
EP. 6: Tucatinib for the Treatment of HER2+ Breast Cancer
December 24th 2019
EP. 7: Margetuximab for the Treatment of HER2+ Breast Cancer
December 24th 2019
EP. 8: The Changing Treatment Landscape of HER2+ Breast Cancer
December 24th 2019
